Pirfenidone Market was valued at USD 1.25 Billion in 2022 and is projected to reach USD 2.35 Billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030.
The global market for Pirfenidone, a drug used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), was valued at approximately USD 1.8 billion in 2022. This market has been experiencing a steady growth trajectory, with a compound annual growth rate (CAGR) of around 8.5% over the past few years. The increase in market size is attributed to the rising prevalence of IPF and the expanding therapeutic indications for Pirfenidone. As healthcare systems evolve and awareness of IPF improves, the demand for effective treatments like Pirfenidone is expected to grow significantly, driving market expansion.
Opportunity analysis reveals considerable potential in emerging markets where the incidence of IPF is on the rise due to increasing environmental pollution and aging populations. These regions present untapped opportunities for market players, as the need for advanced and accessible treatment options continues to grow. The global push towards enhancing healthcare infrastructure and improving access to specialized medications in these areas further supports market potential. As such, stakeholders are keenly focusing on these emerging markets to capitalize on the increasing demand and expand their market footprint.
Get an In-Depth Research Analysis of the Global Pirfenidone Market Size And Forecast [2025-2032]
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Pirfenidone Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Pirfenidone Market
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other
Based on Types the Market is categorized into Below types that held the largest Pirfenidone market share In 2023.
Tablet
Capsule
Other
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pirfenidone Market Research Analysis
1. Introduction of the Global Pirfenidone Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Pirfenidone Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Pirfenidone Market, By Type
6. Global Pirfenidone Market, By Application
7. Global Pirfenidone Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Pirfenidone Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/